Delayed adverse reactions to total-dose intravenous iron polymaltose.

摘要

We read with interest the report by Haines and Gibson documenting a delayed adverse reaction to total-dose infusion of iron polymaltose in 26% of their patients, including severe systemic reactions in 8% of patients.1 We wish to report the rarity of such adverse reactions with routine use of pre-medication with anti-histamine and corticosteroids.